The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Playing hard ball by the looks of it.
Let's hope they drive the business forward with the same sort of verve, assuming it all comes together. It's all that's really missing here
25th Oct 2023 7:00 am RNS Statement regarding possible offer
"Statement regarding possible offer for TMT Acquisition plc
The boards of Belluscura plc (AIM: BELL) and TMT Acquisition plc ("TMT Acquisition") announced on 3 October 2023 that they had reached agreement on the key terms of a possible share for share offer for TMT Acquisition by Belluscura (the "Possible Offer").
Both companies have completed confirmatory due diligence and expect to be in a position to announce a firm offer shortly, and by not later than 5.00 p.m. on 31 October 2023. The terms of the Possible Offer have been revised and will now comprise the issuance of 3 new ordinary shares of Belluscura ("Belluscura Shares") in exchange for every 4 ordinary shares of TMT Acquisition ("TMT Acquisition Shares") equaling 20,625,000 Belluscura Shares (the "Revised Exchange Ratio").
The Revised Exchange Ratio would imply a valuation of 20.25 pence for each TMT Acquisition Share based upon the Belluscura closing middle market price of 27.0p on 24 October 2023, being the last practicable date prior to the announcement of the Revised Possible Offer (the "Revised Possible Offer Terms").
Accordingly, on the basis of the Revised Exchange Ratio, the Revised Possible Offer Terms will imply a total valuation of £5.57 million for TMT Acquisition, representing a premium of approximately:
· 19.12% to the closing price of a TMT Acquisition Share of 17.0p on 24 October 2023, being the last business day before this announcement; and
· 14.30% to the TMT Acquisition three-month volume weighted average price for the period ending 24 October 2023, being the last business day before this announcement.
The independent director of TMT Acquisition, Paul Tuson (the "Independent TMT Acquisition Director"), has reconfirmed to Belluscura that, should a firm offer be made on the Revised Possible Offer Terms (as outlined above), the Independent TMT Acquisition Director is minded to recommend it to TMT Acquisition shareholders. ..."
https://www.lse.co.uk/rns/BELL/statement-regarding-possible-offer-4rxgolfitvrgx30.html
So, improved terms for TMTA, to reflect the dip in the BELL s.p. - these were probably necessary to get the deal approved by TMTA.
Previously, the provisional arrangement was 15 BELL shares for every 22 TMTA shares; now the intended arrangement will equate to 16.5 BELL shares for every 22 TMTA shares: i.e. TMTA shareholders should get 10% more than previously.
The current BELL s.p. is 26.5p (25p - 28p): which based on 3 BELL shares for every 4 TMTA shares equates to 19.875p (18.75p - 21p) TMTA.
But TMTA is currently 17p (16p - 18p), giving a reasonably attractive arbitrage opportunity here again, especially if you can get inside the headline spreads.
Reminds me of a half page advert in the Sunday Times for the newspaper back in the 70’s – pictured the charge of the Light Brigade in full flow, with a caption ‘Ever wished you’d be better informed’.
Just joking, personally I think it will settle in a few weeks once the variables disappear and bounce back to a degree – selling now will simply crystalise losses, but can understand if things are tight and you can’t take the risk – fingers crossed and all that!!
It's a tricky one to call I think , but in balance I think the deal will go through at Bell will be financed for a good period of time allowing them to realize the demand . I'm sticking but not adding as I can see a bit of turmoil before we get over the line
Getting a bit complex for us simple folk to understand without all the background facts! – perhaps they have been driving down Bells price to get a better deal, or perhaps TMT want to benefit from the overall global share price reductions as they are sought of cash buyers – we wont know until the end of the month if they go ahead – no doubt if the markets improve it will definitely go ahead?
I guess you and I have to decide to stay and enjoy the roller coaster ride – I'm sticking with it as I need a bit of excitement!!
At stroke of a pen bell give 10% more
15/22
Now 15/20
On the back of dropping share price
More dilution based
My point is
The time to rent , hire, contracts, affordability checks, delivery, collection then supported legal bits when people default/don’t return
All takes time and money. They have 6500 unit’s ordered. They have not yet been produced/manufactured but they are now looking at ways to offload more units via rentals etc
Perfectly fine to maximise sales. Maximise everywhere
My point is you have stock for rent… they aren’t being bought!
I thought rationale was sound
"Not sure why you would waste time and money on this program if your stock was selling! If you had stock sat there doing nothing then yes" - I found this to be a particularly silly comment. You obviously want to maximise sales from all channels.
Nothing of note here. Not sure it was RNS worthy. Just an update on numbers produced so far and how many out door. That’s all we need.
Not sure why you would waste time and money on this program if your stock was selling! If you had stock sat there doing nothing then yes….
New sales pipeline which looks interesting and funding looks sorted
Onwards and upwards
25p sell price…..
Word has not reached some
Posted by FlagStaffiR on TEK site today - interesting
https://stonegateinc.reportablenews.com/pr/stonegate-initiates-coverage-on-belluscura-plc-aim-bell
"Did you know that the technology in today’s oxygen concentrators is basically unchanged from oxygen tech from the 1970s? We need to do better! Join us to raise awareness and support for those on oxygen therapy leading up to #WorldOxygenDay on October 2nd.
For the last 40 years, supplemental oxygen therapy has been a mainstay treatment for millions of people of all ages living with respiratory problems. These people rely upon oxygen therapy to relieve the symptoms like breathlessness and limited activity caused by chronic problems like COPD, as well as more acute conditions like pneumonia and sleep problems. Despite its ability to add years to people’s lives and life to their years, advancements in oxygen therapy technology have been very slow to happen. The COVID-19 pandemic made the problem even worse by increasing the demand for oxygen equipment as well as straining supply chains. Many people who could benefit from oxygen therapy do not use it as prescribed because of the inconvenience, the cost, or the stigma that can be attached to it.
There are simply too many systemic challenges for people to use oxygen therapy effectively to live their best lives. World Oxygen Day was created to change that.
Sign up to get involved: copdf.co/worldO2Day
Learn more about World Oxygen Day: www.worldoxygenday.org "
https://www.copdfoundation.org/Take-Action/Get-Involved/World-Oxygen-Day.aspx
There are multiple points from this piece of relevance to BELL:-
1. The outdated oxygen technology, that BELL is 'disrupting'.
2. The long-standing (decades) importance of oxygen treatment.
3. The COVID-19 pandemic increasing demand for oxygen equipment.
These points help to explain why, in my opinion, BELL is the most exciting UK new issue of the last few years.
And perhaps of the forseeable future too, if the support of TMTA's billion-pound track record 'shellmeisters' is anything to go by.
Big , totally agree . I also found myself looking some of these investors up and there are some rather large hitters amongst them
GLA
Patience required I’m afraid!! – If you want something to do in the meantime, google some of the names on these forms 8.3 RNS – a reasonable line up of experienced/wealthy investors, some in the medical field – it gives me comfort that people who know these types of products have chucked their money in – nothing is for certain, but don’t panic Captain Mainwaring – not yet in any case!!!
would be appreciated soon, seeing as all my other investments are going ***s up right now !
You'd be hard pushed to find more confident-sounding outlook statements than BELL's recently.
But it's not just words: it's backed up by a new $55M. royalty deal, and attracting the investment of TMTA's billion-pound track record 'shellmeisters'.
And now with the requisite funding arranged, the company is all set to really start motoring.
BELL's market cap. could certainly be hundreds of millions within a few years I would think, and indeed this share looks to have excellent ten-bagger potential from its current level of just 27p.
13th Sep 2023 7:00 am RNS Half-year Report
" ... Post Period End:
Transformational Exclusive License and Royalty Generating Agreement with InnoMax
• Belluscura exclusively licensed its proprietary technology to InnoMax in China, Hong Kong, Macau and Singapore in a deal valued at $55m in minimum royalties over the term of the license ...
Adam Reynolds, Chairman of Belluscura, commented:
"The team at Belluscura has made considerable headway which will enable significant momentum in the business.
"We believe the signing of the groundbreaking Exclusive License and Royalty Generating Agreement with InnoMax, an affiliate of the world's leading electronics manufacturing company, will be transformational for the Group.
"Belluscura is, therefore, well positioned to achieve its expectations in the coming years. The initial response from the market in the Group's products is hugely positive and, as we scale up the business, we expect substantial growth over the coming years, leaving the Board highly confident in Belluscura's future." ...
Outlook
We have made considerable progress with building the foundations for significant growth in the coming years.
Trading since the period end is in line with our expectations for the full year, which is significantly second half weighted. Demand for X-PLOR®, which is predominantly a Direct-to-Consumer unit, is growing, and we expect that our affiliation with GoodRX, and our own direct sales will lead to significantly higher Gross Margins as we utilise the Company's previously high inventory levels.
The demand and orders already received for DISCOV-R are very exciting, and we believe the signing of the groundbreaking Exclusive License and Royalty Generating Agreement with InnoMax, an affiliate of the world's leading electronics manufacturing company, will be transformational for the Group.
The Company is well positioned to deliver substantial growth in the coming years, and we look forward to the future with confidence. ..."
https://www.lse.co.uk/rns/BELL/half-year-report-4yrkeunjaw1bwfs.html
13th Sep 2023 7:00 am RNS Half-year Report
" ... Additionally, the Company continues to drive innovation in telemedicine and artificial intelligence with its proprietary NOMAD biometric app. The NOMAD app will allow users of the DISCOV-R to track performance data on their concentrator and connected devices such as an Apple® or Samsung® Watch, FitBit® device or Nonin® and Masimo® pulse oximeters. The collective information can then be provided to a patient's healthcare provider in person or remotely.
The Company is already working on the next-generation NOMAD app that will alert patients when their blood oxygen saturation level has varied beyond parameters set by their doctor, which is expected to help patients better monitor their conditions, but also improve the efficiency of the device by delivering supplemental oxygen as needed. ..."
https://www.lse.co.uk/rns/BELL/half-year-report-4yrkeunjaw1bwfs.html
"BELL - onging together
Does the TMT Acquisition acquistion make sense?
THE OAK BLOKE
OCT 4, 2023
... I’m struck by the comment that their input will be highly useful. It suggests the “App” and Software side of Belluscura has further to run as I’ve theorised in past articles. ..."
https://theoakbloke.substack.com/p/bell-onging-together
This dovetails with part of the "Future Opportunities" section of the Belluscura AIM admission document, 24 May 2021:-
"Future Opportunities
Biometric Drug & Device Data
The Directors believe that following the launches of the products above, there is a significant opportunity to enhance these devices by collecting and collating Smart data.
Through the integration of biometric data from smart devices, Belluscura would be able to collate valuable clinical data to aid patients’ clinicians to better understand the use of the device and in turn allow clinicians to better assess their patients’ changing needs.
Integration possibilities include:
GPS Smart Watch Activity, movement, location, altitude, heart rate, stress levels, sleep patterns
Smart Pulse Oximeter Blood saturation - SaO2
Smart Inhaler Providing medication information
X-PLO2R (with Bluetooth) Oxygen flow setting and breathing rate
Collecting this information through a Belluscura COPD App the Company should be able to provide a fuller overall picture of a patient’s circumstances, activity and functionality to the clinician, making the X-PLO2R range of products a more valuable proposition.
Devices beyond X-PLO2R
Belluscura also has three further products in development, which utilise the same technology as the X-PLO2R but for larger units:
HO2ME HO2ME is a prototype of the X-PLO2R but is stationary and for home use. HO2ME is expected to be able to deliver 5-10L of continuous oxygen and is intended for Stage 4 COPD patients.
VENTO2LAT-R A non-invasive portable ventilator.
ECMO2 Device Extra-Corporeal Membrane Oxygen (“ECMO”) has for many years been used for patients with life-threatening hypoxaemia and hypercarbia. Positive outcomes by patients who suffered from SARS or Swine Flu has resulted in ECMO becoming a recommended treatment for patients with severe acute respiratory distress syndrome. Belluscura is developing a portable ECMO product (“ECMO2”) to serve this market."
https://api.mziq.com/mzfilemanager/v2/d/4ded0106-ef0f-40e7-b5cf-bca85c2594fd/32e973ea-fb68-d889-a030-50c914c1ff14?origin=1
https://www.belluscura.com/corporate-governance/constitutional-documents/
I think a positive interview sends it up low 30s.
My guess would be more orders announced before Xmas gets it to 40p.
Not seeing a massive amount of selling here myself. Just small PI sales bar one huge sell for £182k yestereday. That probably took a while to put together and it's what's trashed the share price from 50pish. Doesn't take much. We saw what happened when TEK sold a million quids worth. literally halved the SP whilst they were putting it together.
A nice bit of news, any news should see a turn about. Other than the RTO related stuff, anything due ?
Seaman
We have to accept that there is a big seller out there. I promised myself I’d sell some at 48.
I sold some at 48 but not from correct account. So I bought back within the day and actually paid same price which was handy!
Next day I went to sell what I promised I would. It was under 46. So I got angry and waited!
In fairness I would have bought back at 36….
This sell off started after results and has continued constantly. These people have the phone direct to the company. But so do those invested at 32p…. One is right one wrong
We hope we are right
I will set 48p target again! But only for those I bought at cheaper price.
My main holding is at 96p I think
I’ll take £1.50 takeover today mind you. I’m not a greedy man.
Hopefully November has production update. I suspect Paul from vox will try interview. He has loads… and you know that by how pale he looks when he talks the company up!
What we would like to see is 1600 made a month and QA’d. Out gone and hopefully come one could pay for them this time!
This is their time
Only they can c&ck it up now
Not particularly where I thought we would be given the funding steam that seems to have been secured with TM. It would have been good for Bob to have set everything out in an interview maybe to allay any fears or I guess he may wait till the money is in the bank . Either way you can't ignore the fact we are not a million miles away from the lows
Keeping the faith ....although close
Zero TMT trades. Post results it’s been clear someone is clearing out
They still selling
It’s now about making device and good quality
And good quantity
Someone large is getting out. But not us
Ongoing selling to buy TM